Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Urinary Protein Predicts Cognitive Decline

By LabMedica International staff writers
Posted on 06 Dec 2010
Small amounts of albumin in the urine strongly predict faster cognitive decline in older women. More...


When urinary albumin concentrations, at levels not traditionally considered clinically significant, are matched with creatinine levels in women, they can be used to foresee deterioration in those women's mental health.

In a study carried out at Brigham and Women's Hospital, (Boston, MA, USA), 1,200 female participants aged over 70 years, were tested for general cognition over a lengthy period. This included verbal and word memory, verbal fluency (speed in making word associations), and working and short-term memory. The participants with a urinary albumin-to-creatinine ratio of greater than 5 μg/mg at the start of the study experienced cognitive decline at a rate two to seven times faster in all cognitive measures than that attributed to aging alone over an average six years of follow-up.

Julie Lin, MD, author of the study, said, "The strongest association was seen with a decline in the verbal fluency score, which has been attributed to progressive small vessel disease in the brain, which supports the view that albuminuria is an early marker of diffuse vascular disease." The aging US population is at risk for cognitive decline and vascular disease. This simple, noninvasive screening for albumin in the urine as an independent predictor for subsequent cognitive decline may represent an important public health issue. The study was presented at the annual meeting of American Society of Nephrology held in Denver, CO, USA, November 16-21, 2010.

Related Links:

Brigham and Women's Hospital




Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Drug Testing Assays
Atellica DT 250 Analyzer
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: A new study links broad genomic sequencing before first-line therapy to longer survival, supporting its role in treatment decisions (Image Credit: Shutterstock)

Study Supports Broad Genomic Profiling Before First-Line Lung Cancer Treatment

Biomarker testing plays a critical role in advanced non-small cell lung cancer by identifying patients who may benefit from targeted therapies. However, testing only one or two genes can miss actionable... Read more

Immunology

view channel
Image: The findings underscore the importance of aligning allergy testing with clinical history and diagnostic guidelines to reduce inappropriate testing and its consequences (Image Credit: iStock)

Survey Finds Gap Between Food Allergy Testing Awareness and Clinical Practice

Food allergy evaluation can be challenging when laboratory results do not match clinical symptoms. Broad food allergy panels may detect sensitization without confirming an actual allergy, potentially leading... Read more

Industry

view channel
Image Credit: iStock

C2N Makes PrecivityAD2 Alzheimer’s Blood Test Available to Clinicians

Diagnosing Alzheimer’s disease can be challenging, particularly in patients with mild cognitive impairment or early dementia. Assessing brain amyloid pathology can guide clinical decisions, but diagnostic... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.